MyRareDiet A Novel Diet Tracking Tool
MRD
MyRareDiet™: A Diet Tracking, Monitoring and Optimization mHealth Tool for Patients With Inborn Errors of Metabolism
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
The investigators propose to develop and validate MyRareDiet® (MRD) to address an unmet need in the inborn errors of metabolism (IEM) population to assist with dietary management designed to increase adherence and compliance to treatment guidelines, while facilitating the collection of dietary data from individuals with IEM for research purposes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2024
CompletedFirst Posted
Study publicly available on registry
October 30, 2024
CompletedStudy Start
First participant enrolled
November 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedOctober 30, 2024
October 1, 2024
11 months
October 26, 2024
October 28, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Energy
Total reported energy intake
24 hour
Protein
Total percent of calories from protein
24 hour
Secondary Outcomes (2)
Carbohydrate
24 hour
Fat
24 hour
Study Arms (2)
MyRareDiet
EXPERIMENTALMyRareDiet (MRD) entries: Participants will enter their dietary intake into the MyRareDiet app on a series of three random nonconsecutive days. Participants will receive reminders from both OHSU bionutritionist (via email, phone, or text) and from the MRD system to record their dietary intake on the MRD app for particular randomized days.
24 hour recall
ACTIVE COMPARATOR24-hour diet recalls: A series of three randomized nonconsecutive days of 24-hour food recall interviews by telephone will be completed by trained OHSU Bionutrition personnel to determine nutrient intake. Dietary intake will be evaluated with on Nutrition Data System for Research (NDSR) and Metabolic Pro nutrient databases.
Interventions
Participants will record their dietary intake on the MyRareDiet (MRD) app and nutrient content will be assessed to validate MRD compared to a traditional interviewer assessed 24 hour recall.
A trained nutritionist will conduct a telephone multi-pass 24 hour diet recall on 3 randomized nonconsecutive days. The dietary intake will be analyzed using NDSR and metabolic pro and nutrient intake will be compared to the nutrient intake assessed with the MRD app.
Eligibility Criteria
You may qualify if:
- diagnosed with urea cycle disorder, propionic acidemia, maple syrup urine disease or methylmalonic acidemia
- consuming a diet where ≥50% of energy is supplied by foods consumed orally
- self-known (or prescribed) dietary energy goal and protein restriction
- internet connected device to access MyRareDiet
You may not qualify if:
- pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dershung Yang, PhD
BrightOutcomes, Inc.
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 26, 2024
First Posted
October 30, 2024
Study Start
November 15, 2024
Primary Completion
September 30, 2025
Study Completion
December 31, 2025
Last Updated
October 30, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share
The confidentiality of subjects' data will be maintained by use of de-identification procedures. Informed consent forms that include the subject's name will be stored separately in locked file cabinets. Electronic records will be handled according to HIPAA rules where individually identifiable data, such as names, any identification numbers and certain demographic information, are stored separately and password-protected so that they can be accessed only by the project Investigators. A unique subject identifier (ID) will be generated for each participant and used by the subject to access the developed prototype system and for researchers to retrieve information related to a specific subject. At the end of this study, all patient identifiable data in all formats will be completely destroyed.